We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 13/10/2020 17:44 | Knock, knock. Your friendly Stampy here again. Those on the LSE are now fretting over a placing and their holdings being diluted to oblivion! This isn't some lifestyle CEO mining exploration company. This company has the country's leading experts in respiratory medicine. May I point to history, and Porton International again, and their quest for the treatment and vaccine for herpes which was sweeping across the US and Europe in the 1980s. The city raised millions from big business, namely, Legal and General, Lloyds Bank, Sun Alliance, and the pension funds of ICI, BT, and the Post Office. The story has only begun. IMO. DYOR of course. | stampylong trader | |
| 13/10/2020 17:41 | About 2m late reported. | wetdream |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
